Rob C Holmes
CIK 1845093 · Chairman, President and CEO · last filed 2026-06-08
Rob C Holmes is a Chairman, President and CEO who has filed 28 SEC Form 4 insider transactions across 3 companies since 2021. Across all open-market trades the lifetime net is −$9.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $34.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TCBIO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DALLAS, TX 75201
Holdings By Company
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | — | Notice (144) | −49,500 | -$5.01M | EDGAR |
| 2026-06-09 | — | Notice (144) | −49,100 | -$5.00M | EDGAR |
| 2026-06-08 | TCBIO | Sell (S) | −98,600 | -$10.01M | EDGAR |
| 2026-06-01 | DDT | Grant (A) | +300 | $177.9K | EDGAR |
| 2026-02-23 | TCBIO | Mixed | — | -$141.2K | EDGAR |
| 2026-02-17 | TCBIO | Mixed | +6,026 | -$366.1K | EDGAR |
| 2026-02-10 | TCBIO | Mixed | +18,161 | -$1.20M | EDGAR |
| 2026-01-30 | TCBIO | Mixed | +5,796 | -$422.6K | EDGAR |
| 2025-05-19 | DDT | Grant (A) | +400 | $165.8K | EDGAR |
| 2025-02-18 | TCBIO | Mixed | +5,801 | -$305.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.